1. Hexamethylmelamine: pharmacology and mechanism of action;Ames;Cancer Treat. Rev.,1991
2. Inhibition of the Crocker mouse sarcoma 180 by certain ethyleneimine derivatives and related compounds;Buckley;Cancer Res.,1950
3. Phase I and pharmacological studies of pentamethylmelamine administered by a 24hr intravenous infusion;Caspar;Cancer Res.,1981
4. Rationale for the development of stable water soluble analogues of the s-triazine trimelamol;Coley,1993
5. Stable analogues of the antitumour agent trimelamol retain in vitro cytotoxicity in drug-sensitive and resistant rodent and human cell lines;Coley;Eur. J. Cancer,1994